Nasdaq

Tevogen Bio Files Patent for Innovative T Cell Vaccine Targeting Entire Viral Genome to Combat Mutations

Tevogen Bio files patent for T cell vaccine targeting entire viral genome, enhancing immune response against mutations and viral infections. Tevogen Bio, a clinical-stage immunotherapy biotech company ...
Nasdaq

Applied DNA Awarded Contract by HDT Bio For Rapid Vaccine Development Program

STONY BROOK, NY / ACCESSWIRE / April 25, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, today announced the award of a contract from HDT Bio for ...
FOX40 News

HDT Bio to Help Spearhead RNA Vaccine Development in National Pandemic Preparedness Initiative

HDT bio's Rapid-Response Roadmap for RNA vaccines (R 4) project granted a five-year subaward for $2M per year HDT Bio will focus on developing "road maps" for the rapid creation of RNA vaccines ...
Yahoo Finance

Apriori Bio and A*STAR Infectious Diseases Labs Announce Strategic Partnership to Advance Next Generation Influenza Vaccines

CAMBRIDGE, Mass. and SINGAPORE, Nov. 18, 2025 /PRNewswire/ -- Apriori Bio, a Flagship Pioneering company focused on developing prospective, variant-resilient vaccines, and the Agency for Science, ...
News Medical

Apriori Bio and A*STAR collaborate to develop next-generation saRNA influenza vaccines

Apriori Bio, a Flagship Pioneering company focused on developing prospective, variant-resilient vaccines, and the Agency for Science, Technology and Research Infectious Diseases Labs (A*STAR IDL) ...